Has Richard Gordon received payments from drug or device companies?

Yes. Drug and device makers reported $2,593 in general payments to Richard Gordon across 120 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Gordon did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Gordon come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Gordon

Pediatrics · Tulsa, OKNPI 1972557585

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Corium, LLC at 42.5% of the total. Among pediatrics clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,593in general payments, 2019–2025

Across 120 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corium, LLC$1K
Novo Nordisk$619
Supernus Pharmaceuticals, Inc.$119
Lilly USA, LLC$116
Pfizer$81
Boehringer Ingelheim$56
plus $500 from 19 others

$1,216in research payments, 2019–2025

Across 7 payments — averaging $173.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$1K

What the payments were for

Food & beverage$2,593100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corium, LLC	37	$1,101
Novo Nordisk	35	$619
Supernus Pharmaceuticals, Inc.	5	$119
Lilly USA, LLC	6	$116
Pfizer	5	$81
Boehringer Ingelheim	4	$56
Dexcom, Inc.	2	$49
Xeris Pharmaceuticals, Inc.	2	$49
GSK	3	$48
Kowa Pharmaceuticals America, Inc.	3	$44
Collegium Pharmaceutical, Inc.	2	$39
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$36
Bayer	2	$28
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$23
Johnson & Johnson	1	$23
AbbVie	1	$22
Ironshore Pharmaceuticals Inc.	1	$21
Alk-abello, Inc	1	$21
AstraZeneca	1	$20
Exact Sciences	1	$16
Abbott	1	$15
Genentech USA, Inc.	1	$13
Sunovion Pharmaceuticals Inc.	1	$12
Tris Pharma Inc	1	$12
Takeda Pharmaceuticals U.S.A., Inc.	1	$10

How this compares

$2,593 in reported general payments places this provider in the 95th percentile of 568 pediatrics providers in Oklahoma.

See all pediatrics providers in Oklahoma →

Other pediatrics in Tulsa

Stanley GroggTulsa$24K
Angela ConradTulsa$6K
Todd ColemanTulsa$5K
Patrick DaleyTulsa$5K
Stacy O'SullivanTulsa$4K
Uyen leTulsa$4K
Christine NarrinTulsa$4K
Jerry FreedTulsa$4K
Sang WanTulsa$3K
Donald ZetikTulsa$3K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →